• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽缀合的磷酰二胺吗啉代寡核苷酸的分子特性及分子内相互作用

Molecular properties and intramolecular interactions of peptide-conjugated phosphorodiamidate morpholino oligonucleotides.

作者信息

Kliuchnikov Evgenii, Maksudov Farkhad, Pierson Daniel, Marx Kenneth A, Chanda Arani, Barsegov Valeri

机构信息

Department of Chemistry, University of Massachusetts, Lowell, MA 01854, USA.

Technical Operations, Sarepta Therapeutics, Cambridge, MA 02142, USA.

出版信息

Mol Ther Nucleic Acids. 2025 Aug 14;36(3):102685. doi: 10.1016/j.omtn.2025.102685. eCollection 2025 Sep 9.

DOI:10.1016/j.omtn.2025.102685
PMID:40917895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12408397/
Abstract

We combined circular dichroism (CD) and viscosity measurements with molecular dynamics (MD) simulations and classification and regression approaches to machine learning to characterize solution structures of 22-mer, 25-mer, and 30-mer peptide- (-GlyArg6) conjugated phosphorodiamidate morpholino oligonucleotides (PPMOs). PPMO molecules form non-canonical folded structures with 1.4- to 1.5-nm radius of gyration, 4-6 base pairs and 5-11 base stacks, characterized by -49 to -71 kcal/mol free energy of folding. The 4.5-6.1 cm/g intrinsic viscosity and Huggins constant of 4.5-9.7 indicate PPMO-PPMO interactions at higher concentrations. The random-coil 3'-end conjugated -GlyArg portion does not alter molecular properties of phosphorodiamidate morpholino oligonucleotide (PMO) components, which explains why CD spectra, viscosity-concentration profiles, and inhibitor activities of 22-mer, 25-mer, and 30-mer PPMOs and PMOs are similar but the peptide enhances the PPMO cellular uptake. PPMOs' viscosity is lower than PMOs' viscosity, due to PMO-peptide position-dependent interactions, especially in 25-mer PPMO, explaining differences in CD and high-concentration viscosity. These results reiterate the importance of the conformational ensemble view of non-canonical PPMO structures in solution, in agreement with our previous PMO study. The addition of -GlyArg does not alter the structure and molecular properties of the PMO components of the PPMO structures but impacts the viscosity of the PPMO-based aqueous solution formulations.

摘要

我们将圆二色性(CD)和粘度测量与分子动力学(MD)模拟以及机器学习中的分类和回归方法相结合,以表征22聚体、25聚体和30聚体肽-(-GlyArg6)共轭磷酰二胺吗啉代寡核苷酸(PPMO)的溶液结构。PPMO分子形成具有1.4至1.5纳米回转半径、4至6个碱基对和5至11个碱基堆叠的非经典折叠结构,其特征在于折叠自由能为-49至-71千卡/摩尔。4.5至6.1厘米/克的特性粘度和4.5至9.7的哈金斯常数表明在较高浓度下PPMO之间存在相互作用。随机卷曲的3'-末端共轭-GlyArg部分不会改变磷酰二胺吗啉代寡核苷酸(PMO)组分的分子性质,这解释了为什么22聚体、25聚体和30聚体PPMO以及PMO的CD光谱、粘度-浓度曲线和抑制剂活性相似,但肽增强了PPMO的细胞摄取。由于PMO-肽位置依赖性相互作用,PPMO的粘度低于PMO的粘度,尤其是在25聚体PPMO中,这解释了CD和高浓度粘度的差异。这些结果重申了溶液中非经典PPMO结构的构象集合观点的重要性,这与我们之前对PMO的研究一致。添加-GlyArg不会改变PPMO结构中PMO组分的结构和分子性质,但会影响基于PPMO的水溶液配方的粘度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/3a75acdf4183/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/26c7caacdf1c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/29d81df50e67/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/7a60398c12c8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/9efe0f0f8298/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/c8c0441df95c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/23eb8f135862/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/ceeb77fc106e/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/a9201dcadfea/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/3a75acdf4183/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/26c7caacdf1c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/29d81df50e67/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/7a60398c12c8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/9efe0f0f8298/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/c8c0441df95c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/23eb8f135862/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/ceeb77fc106e/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/a9201dcadfea/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7a/12408397/3a75acdf4183/gr8.jpg

相似文献

1
Molecular properties and intramolecular interactions of peptide-conjugated phosphorodiamidate morpholino oligonucleotides.肽缀合的磷酰二胺吗啉代寡核苷酸的分子特性及分子内相互作用
Mol Ther Nucleic Acids. 2025 Aug 14;36(3):102685. doi: 10.1016/j.omtn.2025.102685. eCollection 2025 Sep 9.
2
Therapeutic phosphorodiamidate morpholino oligonucleotides: Physical properties, solution structures, and folding thermodynamics.治疗性磷酰胺吗啉代寡核苷酸:物理性质、溶液结构和折叠热力学
Mol Ther Nucleic Acids. 2023 Feb 14;31:631-647. doi: 10.1016/j.omtn.2023.02.007. eCollection 2023 Mar 14.
3
Systemic Injection of Peptide-PMOs into Humanized DMD Mice and Detection by RT-PCR and ELISA.将肽-磷酰二胺吗啉代寡聚物全身注射入人源化杜氏肌营养不良症(DMD)小鼠,并通过逆转录聚合酶链反应(RT-PCR)和酶联免疫吸附测定(ELISA)进行检测。
Methods Mol Biol. 2025;2964:231-242. doi: 10.1007/978-1-0716-4730-1_15.
4
Using muscle homing peptide CyPep10 to deliver phosphorodiamidate morpholino oligomers in the mdx mouse.利用肌肉归巢肽CyPep10在mdx小鼠中递送磷酰二胺吗啉代寡聚物。
Mol Ther Nucleic Acids. 2025 Jul 17;36(3):102625. doi: 10.1016/j.omtn.2025.102625. eCollection 2025 Sep 9.
5
In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.反义磷酰二胺吗啉代寡聚物(PMO)在营养不良犬和第7外显子缺失的杜氏肌营养不良症(DMD)患者中诱导体外多外显子跳跃
Methods Mol Biol. 2025;2964:143-155. doi: 10.1007/978-1-0716-4730-1_9.
6
Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy.在杜氏肌营养不良症的Dup2小鼠模型中,全身性PPMO介导的抗肌萎缩蛋白表达。
Mol Ther Nucleic Acids. 2022 Nov 9;30:479-492. doi: 10.1016/j.omtn.2022.10.025. eCollection 2022 Dec 13.
7
Phosphoramidite Platform for the Automated Synthesis of Morpholino Antisense Oligonucleotides and Their Chimeras.用于自动合成吗啉代反义寡核苷酸及其嵌合体的亚磷酰胺平台。
Curr Protoc. 2025 Jun;5(6):e70162. doi: 10.1002/cpz1.70162.
8
In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.肽基吗啉代寡核苷酸介导的多外显子跳跃在营养不良犬心脏和骨骼肌中的体内评估
Methods Mol Biol. 2025;2964:329-343. doi: 10.1007/978-1-0716-4730-1_22.
9
Exon-Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.使用反义寡核苷酸进行外显子跳跃治疗α2-层粘连蛋白缺乏型肌营养不良症
Methods Mol Biol. 2025;2964:487-499. doi: 10.1007/978-1-0716-4730-1_33.
10
Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysis.杜氏肌营养不良症的真实世界中吗啉代磷酰胺寡聚物治疗模式:基于索赔的分析
J Comp Eff Res. 2025 Aug;14(8):e250037. doi: 10.57264/cer-2025-0037. Epub 2025 Jul 18.

本文引用的文献

1
Effects of arginine in therapeutic protein formulations: a decade review and perspectives.精氨酸在治疗性蛋白质制剂中的作用:十年回顾与展望
Antib Ther. 2023 Oct 12;6(4):265-276. doi: 10.1093/abt/tbad022. eCollection 2023 Oct.
2
Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide.利用 DG9 增强基于反义寡核苷酸的治疗性递药,DG9 是一种多功能的细胞穿透肽。
Cells. 2023 Oct 2;12(19):2395. doi: 10.3390/cells12192395.
3
Cell-Penetrating d-Peptides Retain Antisense Morpholino Oligomer Delivery Activity.
细胞穿透性 d 肽保留反义吗啉代寡聚物递送活性。
ACS Bio Med Chem Au. 2022 Feb 16;2(2):150-160. doi: 10.1021/acsbiomedchemau.1c00053. eCollection 2022 Apr 20.
4
Recent Trends in Antisense Therapies for Duchenne Muscular Dystrophy.杜氏肌营养不良症反义疗法的最新趋势
Pharmaceutics. 2023 Feb 26;15(3):778. doi: 10.3390/pharmaceutics15030778.
5
Therapeutic phosphorodiamidate morpholino oligonucleotides: Physical properties, solution structures, and folding thermodynamics.治疗性磷酰胺吗啉代寡核苷酸:物理性质、溶液结构和折叠热力学
Mol Ther Nucleic Acids. 2023 Feb 14;31:631-647. doi: 10.1016/j.omtn.2023.02.007. eCollection 2023 Mar 14.
6
Chemistry, structure and function of approved oligonucleotide therapeutics.已获批的寡核苷酸治疗药物的化学、结构和功能。
Nucleic Acids Res. 2023 Apr 11;51(6):2529-2573. doi: 10.1093/nar/gkad067.
7
Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections.细胞穿透肽在作为有前途的药物载体对抗病毒感染中的应用。
Mol Biotechnol. 2023 Sep;65(9):1387-1402. doi: 10.1007/s12033-023-00679-1. Epub 2023 Jan 31.
8
Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer.细胞穿透肽(CPPs)作为癌症的治疗和诊断剂
Cancers (Basel). 2022 Nov 11;14(22):5546. doi: 10.3390/cancers14225546.
9
Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy.在杜氏肌营养不良症的Dup2小鼠模型中,全身性PPMO介导的抗肌萎缩蛋白表达。
Mol Ther Nucleic Acids. 2022 Nov 9;30:479-492. doi: 10.1016/j.omtn.2022.10.025. eCollection 2022 Dec 13.
10
A cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate morpholino oligomers in mice.一种细胞穿透肽可增强磷酰二胺吗啉代寡聚物在小鼠体内的递送及疗效。
Mol Ther Nucleic Acids. 2022 Aug 17;30:17-27. doi: 10.1016/j.omtn.2022.08.019. eCollection 2022 Dec 13.